Statement Of Cash Flows [Abstract]
| Concept |
2023-01-01 to 2023-12-31 |
2022-01-01 to 2022-12-31 |
|---|---|---|
| Statement of cash flows [abstract] | ||
| Cash flows from (used in) operating activities [abstract] | ||
| Adjustments for interest expense |
339,000
EUR
|
146,000
EUR
|
| Adjustments for deferred tax expense |
449,000
EUR
|
640,000
EUR
|
| Cash flows from (used in) operations before changes in working capital |
3,947
EUR
|
8,833
EUR
|
| Adjustments for decrease (increase) in other assets |
743,000
EUR
|
0
EUR
|
| Adjustments for increase (decrease) in other liabilities |
1,271
EUR
|
310,000
EUR
|
| Adjustments for increase (decrease) in employee benefit liabilities |
106,000
EUR
|
12,000
EUR
|
| Adjustments for decrease (increase) in biological assets |
32,000
EUR
|
1,479
EUR
|
| Adjustments for impairment loss (reversal of impairment loss) recognised in profit or loss, property, plant and equipment |
0
EUR
|
1,636
EUR
|